Correlation Between Bristol Myers and Medpace Holdings
Can any of the company-specific risk be diversified away by investing in both Bristol Myers and Medpace Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol Myers and Medpace Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bristol Myers Squibb and Medpace Holdings, you can compare the effects of market volatilities on Bristol Myers and Medpace Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol Myers with a short position of Medpace Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol Myers and Medpace Holdings.
Diversification Opportunities for Bristol Myers and Medpace Holdings
-0.41 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Bristol and Medpace is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and Medpace Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medpace Holdings and Bristol Myers is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with Medpace Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medpace Holdings has no effect on the direction of Bristol Myers i.e., Bristol Myers and Medpace Holdings go up and down completely randomly.
Pair Corralation between Bristol Myers and Medpace Holdings
Considering the 90-day investment horizon Bristol Myers Squibb is expected to generate 0.82 times more return on investment than Medpace Holdings. However, Bristol Myers Squibb is 1.22 times less risky than Medpace Holdings. It trades about 0.19 of its potential returns per unit of risk. Medpace Holdings is currently generating about 0.05 per unit of risk. If you would invest 5,264 in Bristol Myers Squibb on August 28, 2024 and sell it today you would earn a total of 614.00 from holding Bristol Myers Squibb or generate 11.66% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Bristol Myers Squibb vs. Medpace Holdings
Performance |
| Timeline |
| Bristol Myers Squibb |
| Medpace Holdings |
Bristol Myers and Medpace Holdings Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Bristol Myers and Medpace Holdings
The main advantage of trading using opposite Bristol Myers and Medpace Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol Myers position performs unexpectedly, Medpace Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medpace Holdings will offset losses from the drop in Medpace Holdings' long position.| Bristol Myers vs. Capricor Therapeutics | Bristol Myers vs. Soleno Therapeutics | Bristol Myers vs. Bio Path Holdings | Bristol Myers vs. Moleculin Biotech |
| Medpace Holdings vs. IQVIA Holdings | Medpace Holdings vs. Neogen | Medpace Holdings vs. ICON PLC | Medpace Holdings vs. Qiagen NV |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |